Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor

Multiple evanescent white dot syndrome (MEWDS) is an inflammatory condition of the retina that typically presents unilaterally with multiple gray-white spots in the outer retina or retinal pigmented epithelium and granular changes within the fovea. We report a case of new-onset MEWDS in a patient cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Boutros, Heidi, Okeagu, Chinwenwa, Sharma, Aman, Shaikh, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Ophthalmology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040745/
https://www.ncbi.nlm.nih.gov/pubmed/33859903
http://dx.doi.org/10.7759/cureus.13853
_version_ 1783677837573619712
author Boutros, Heidi
Okeagu, Chinwenwa
Sharma, Aman
Shaikh, Saad
author_facet Boutros, Heidi
Okeagu, Chinwenwa
Sharma, Aman
Shaikh, Saad
author_sort Boutros, Heidi
collection PubMed
description Multiple evanescent white dot syndrome (MEWDS) is an inflammatory condition of the retina that typically presents unilaterally with multiple gray-white spots in the outer retina or retinal pigmented epithelium and granular changes within the fovea. We report a case of new-onset MEWDS in a patient closely after the initiation of empagliflozin, a sodium-glucose cotransporter inhibitor medicine for his type II diabetes mellitus.
format Online
Article
Text
id pubmed-8040745
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-80407452021-04-14 Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor Boutros, Heidi Okeagu, Chinwenwa Sharma, Aman Shaikh, Saad Cureus Ophthalmology Multiple evanescent white dot syndrome (MEWDS) is an inflammatory condition of the retina that typically presents unilaterally with multiple gray-white spots in the outer retina or retinal pigmented epithelium and granular changes within the fovea. We report a case of new-onset MEWDS in a patient closely after the initiation of empagliflozin, a sodium-glucose cotransporter inhibitor medicine for his type II diabetes mellitus. Cureus 2021-03-12 /pmc/articles/PMC8040745/ /pubmed/33859903 http://dx.doi.org/10.7759/cureus.13853 Text en Copyright © 2021, Boutros et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Boutros, Heidi
Okeagu, Chinwenwa
Sharma, Aman
Shaikh, Saad
Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title_full Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title_fullStr Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title_full_unstemmed Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title_short Multiple Evanescent White Dot Syndrome Presenting After Initiation of Empagliflozin, a Sodium-Glucose Cotransporter-2 Inhibitor
title_sort multiple evanescent white dot syndrome presenting after initiation of empagliflozin, a sodium-glucose cotransporter-2 inhibitor
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040745/
https://www.ncbi.nlm.nih.gov/pubmed/33859903
http://dx.doi.org/10.7759/cureus.13853
work_keys_str_mv AT boutrosheidi multipleevanescentwhitedotsyndromepresentingafterinitiationofempagliflozinasodiumglucosecotransporter2inhibitor
AT okeaguchinwenwa multipleevanescentwhitedotsyndromepresentingafterinitiationofempagliflozinasodiumglucosecotransporter2inhibitor
AT sharmaaman multipleevanescentwhitedotsyndromepresentingafterinitiationofempagliflozinasodiumglucosecotransporter2inhibitor
AT shaikhsaad multipleevanescentwhitedotsyndromepresentingafterinitiationofempagliflozinasodiumglucosecotransporter2inhibitor

Ejemplares similares